ALPS Medical Breakthroughs ETF
SBIO
#2250
ETF rank
C$0.29 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
C$91.61
Share price
2.17%
Change (1 day)
106.36%
Change (1 year)

Expense ratio and fees for ALPS Medical Breakthroughs ETF (SBIO)

Gross Expense Ratio

Gross Expense Ratio as of July 2026: 0.5%

Net Expense Ratio

Net Expense Ratio as of July 2026: 0.5%